Pasireotide

Pasireotide is a synthetic long-acting cyclic hexapeptide with somatostatin-like activity. It is marketed as a diaspartate salt called Signifor®, which is used in the treatment of Cushing's disease.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-169
CAS	396091-73-9
Synonyms/Alias	SOM 230;Pasireotidum
M.F/Formula	C58H66N10O9
M.W/Mr.	1047.20624
Sequence	One Letter Code: cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-LPFWK-4-O-benzyl-YF-) Three Letter Code: cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-Pro-L-Phe-D-Trp-L-Lys-4-O-benzyl-L-Tyr-L- Phe-)
Application	Pasireotide is used for the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery has not been curative or is not an option.

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-197	Pasireotide-d7	1054.25	C₅₈H₅₉D₇N₁₀O₉	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Source#	Synthetic
Storage	-20°C
Shipping Condition	Room temperature
InChI	InChI=1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,47+,48-,49+,50+,51+/m1/s1
InChI Key	VMZMNAABQBOLAK-DBILLSOUSA-N
Canonical SMILES	C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN
Isomeric SMILES	C1[C@H](CN2[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN